By: Erin O Brien
The study sheds light on the potential risks and adverse effects of polypharmacy in patients with complex psychiatric conditions.
Supervisory Health Scientist--Evaluation Team Lead
Erin O'Brien is a Supervisory Health Scientist and Evaluation Team Lead. She writes for Psychiatric Times and Warwick Online, covering a wide range of topics related to mental health, research, and medical advancements. Erin's work has also been featured in PROVIDENCE READING OLYMPICS, showcasing her expertise and commitment to informing and educating readers on important health issues.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Erin O'Brien predominantly covers House & Home topics, with a significant focus on deals and promotions. She frequently features promotional deals and product reviews related to health and wellness, mental health, psychiatry, and medical research. To effectively reach out to Erin, consider pitching content related to household products that promote health and wellness or align with mental health themes.
Given her coverage attributes of Promotional Deal (50%) and Review (20%), she may be open to receiving pitches about new products or services in the areas of mental health support, home healthcare devices or innovative household items that contribute positively to overall well-being.
Erin does not have a specific geographic focus but appears interested in content relevant to a broad audience seeking lifestyle improvements within their homes.
This information evolves through artificial intelligence and human feedback. Improve this profile .